相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Upregulation of AcrEF in Quinolone Resistance Development in Escherichia coli When AcrAB-TolC Function Is Impaired
Chuan-Zhen Zhang et al.
MICROBIAL DRUG RESISTANCE (2018)
Role of newer and re-emerging older agents in the treatment of infections caused by carbapenem-resistant Enterobacteriaceae
Joshua T. Thaden et al.
VIRULENCE (2017)
Tigecycline Susceptibility and Molecular Resistance Mechanisms Among Clinical Klebsiella pneumoniae Strains Isolated During Non-Tigecycline Treatment
Ruilian Li et al.
MICROBIAL DRUG RESISTANCE (2017)
Molecular Epidemiology and Risk Factors of Carbapenem-Resistant Klebsiella pneumoniae Infections in Eastern China
Bing Zheng et al.
FRONTIERS IN MICROBIOLOGY (2017)
Structure of the MacAB-TolC ABC-type tripartite multidrug efflux pump
Anthony W. P. Fitzpatrick et al.
NATURE MICROBIOLOGY (2017)
Deciphering Heteroresistance to Colistin in a Klebsiella pneumoniae Isolate from Marseille, France
Lucie Bardet et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Genomic Characterization of Colistin Heteroresistance in Klebsiella pneumoniae during a Nosocomial Outbreak
Teysir Halaby et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent
George G. Zhanel et al.
DRUGS (2016)
In vivo evolution of tigecycline-non-susceptible Klebsiella pneumoniae strains in patients: relationship between virulence and resistance
Yi-Tsung Lin et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Emergence of tigecycline- and carbapenem-nonsusceptible Klebsiella pneumoniae ST11 clone in patients without exposure to tigecycline
Zi-Ke Sheng et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2016)
Klebsiella pneumoniae: Going on the Offense with a Strong Defense
Michelle K. Paczosa et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2016)
Step-Wise Increase in Tigecycline Resistance in Klebsiella pneumoniae Associated with Mutations in ramR, lon and rpsJ
Li Fang et al.
PLOS ONE (2016)
Activity of Eravacycline against Enterobacteriaceae and Acinetobacter baumannii, Including Multidrug-Resistant Isolates, from New York City
Marie Abdallah et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Differential contribution of AcrAB and OqxAB efflux pumps to multidrug resistance and virulence in Klebsiella pneumoniae
Suzanne Bialek-Davenet et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Imipenem heteroresistance: high prevalence among Enterobacteriaceae Klebsiella pneumoniae carbapenemase producers
Carolina Silva Nodari et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2015)
Eravacycline for the treatment of intra-abdominal infections
Matteo Bassetti et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2014)
Major Variation in MICs of Tigecycline in Gram-Negative Bacilli as a Function of Testing Method
Dror Marchaim et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
First Emergence of acrAB and oqxAB Mediated Tigecycline Resistance in Clinical Isolates of Klebsiella pneumoniae Pre-Dating the Use of Tigecycline in a Chinese Hospital
Xue Zhong et al.
PLOS ONE (2014)
Antibacterial Activity of Eravacycline (TP-434), a Novel Fluorocycline, against Hospital and Community Pathogens
J. A. Sutcliffe et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Tigecycline susceptibility in Klebsiella pneumoniae and Escherichia coli causing neonatal septicaemia (2007-10) and role of an efflux pump in tigecycline non-susceptibility
Subhasree Roy et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Effect of Transcriptional Activators SoxS, RobA, and RamA on Expression of Multidrug Efflux Pump AcrAB-TolC in Enterobacter cloacae
Astrid Perez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
In Vivo Emergence of Tigecycline Resistance in Multidrug-Resistant Klebsiella pneumoniae and Escherichia coli
Teresa Spanu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Target- and Resistance-Based Mechanistic Studies with TP-434, a Novel Fluorocycline Antibiotic
Trudy H. Grossman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient
C. Rodriguez-Avial et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Emergence of tigecycline-resistant Klebsiella pneumoniae after tigecycline therapy for complicated urinary tract infection caused by carbapenem-resistant Escherichia coli
Hsih-Yeh Tsai et al.
JOURNAL OF INFECTION (2012)
Colistin heteroresistance in carbapenemase-producing Klebsiella pneumoniae
Georgios Meletis et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Characteristics of Meropenem Heteroresistance in Klebsiella pneumoniae Carbapenemase (KPC)-Producing Clinical Isolates of K-pneumoniae
Spyros Pournaras et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Correlation of the expression of acrB and the regulatory genes marA, soxS and ramA with antimicrobial resistance in clinical isolates of Klebsiella pneumoniae endemic to New York City
Simona Bratu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Overexpression of the multidrug efflux operon acrEF by insertional activation with IS1 or IS10 elements in Salmonella enterica serovar typhimurium DT204 acrB mutants selected with fluoroquinolones
A Olliver et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Novel macrolide-specific ABC-type efflux transporter in Escherichia coli
N Kobayashi et al.
JOURNAL OF BACTERIOLOGY (2001)
分享论文
